Cargando…
Achieving the “triple aim” for inborn errors of metabolism: a review of challenges to outcomes research and presentation of a new practice-based evidence framework
Across all areas of health care, decision makers are in pursuit of what Berwick and colleagues have called the “triple aim”: improving patient experiences with care, improving health outcomes, and managing health system impacts. This is challenging in a rare disease context, as exemplified by inborn...
Autores principales: | Potter, Beth K., Chakraborty, Pranesh, Kronick, Jonathan B., Wilson, Kumanan, Coyle, Doug, Feigenbaum, Annette, Geraghty, Michael T., Karaceper, Maria D., Little, Julian, Mhanni, Aizeddin, Mitchell, John J., Siriwardena, Komudi, Wilson, Brenda J., Syrowatka, Ania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837195/ https://www.ncbi.nlm.nih.gov/pubmed/23222662 http://dx.doi.org/10.1038/gim.2012.153 |
Ejemplares similares
-
Child and family experiences with inborn errors of metabolism: a qualitative interview study with representatives of patient groups
por: Khangura, Sara D., et al.
Publicado: (2015) -
The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study
por: Karaceper, Maria D., et al.
Publicado: (2016) -
Scoping review of patient- and family-oriented outcomes and measures for chronic pediatric disease
por: Khangura, Sara D, et al.
Publicado: (2015) -
Health services use among children diagnosed with medium-chain acyl-CoA dehydrogenase deficiency through newborn screening: a cohort study in Ontario, Canada
por: Karaceper, Maria D., et al.
Publicado: (2019) -
Stakeholder perspectives on clinical research related to therapies for rare diseases: therapeutic misconception and the value of research
por: Tingley, Kylie, et al.
Publicado: (2021)